Trump Signs Bill Delaying Federal Hemp THC Ban Until December

September 4, 2026

Photo via Unsplash.

Congress just bought itself another month on hemp. On September 3, 2026, President Trump signed H.R. 6500, a government funding package that quietly pushes back the scheduled federal recriminalization of most hemp-derived THC products from November 12 to December 11. It's a stopgap, not a solution — a rider tucked into a must-pass spending bill rather than a standalone piece of hemp policy, and it buys lawmakers roughly 30 extra days to write actual regulation instead of letting a blanket ban take effect by default.

Not everything got delayed, though. Restrictions on synthetic and non-naturally-occurring cannabinoids — the lab-made compounds that don't show up in the cannabis plant on their own — still kick in November 12 as originally scheduled, delay or no delay. That distinction matters a lot to the hemp beverage and gummy makers whose products rely on plant-derived THC rather than synthesized analogs.

The whole mess traces back to the November 2025 government-reopening deal, which redefined hemp using total THC — folding in THCa and delta-8 rather than measuring delta-9 alone — and capped finished products at 0.4 milligrams of total THC per container, a threshold so low it would effectively wipe out most of the intoxicating hemp market as it exists today. Now the industry is hoping this extra month turns into a permanent regulatory framework, while hardliners like Sen. Ted Budd (R-NC) wanted the ban to hit right on schedule. That tension didn't resolve on September 3. It just got postponed.

What the Sept. 3 Signing Actually Changed

H.R. 6500's core job is keeping the federal government funded past the September 30 end of the fiscal year, and it does that through December 11. The hemp provision is a rider riding along on that larger vehicle, which is standard practice in Washington but also explains why it's a narrow fix rather than a rewrite. Congress didn't sit down and hash out what hemp THC regulation should look like long-term. It attached a 30-day extension to a bill that had to pass anyway, because nobody wanted a government shutdown fight and a hemp market collapse happening in the same news cycle.

How the Bill Got Through Congress

The path to Trump's desk wasn't smooth. The House passed the broader funding package 370-48 the preceding Tuesday, a comfortable margin that reflected how little appetite there was for another shutdown standoff. The Senate was messier. Republicans reportedly held a tense closed-door meeting where James Braid, the White House Director of Legislative Affairs, promised there would be no further extensions if this delay went through — a commitment meant to reassure members worried about kicking the hemp question down the road indefinitely.

That promise looks shakier by the day. Braid was reported to be leaving the administration in September, shortly after making it, which raises an obvious question: who inside the White House actually holds that line if the person who drew it is gone? Senate hardliners weren't fully persuaded even before that news broke. Sen. Ted Budd offered an amendment to strip the hemp delay out of the bill entirely, forcing the ban to proceed on the original November 12 timeline. The Senate tabled it, 61-32, and then passed the full funding package 90-6. Budd and his allies argue the delay doesn't fix anything — it just resets the clock on the same unresolved fight, and they're not wrong about that part.

The Regulatory Bills Still Stuck in Committee

The real action, if it ever happens, sits in a pile of bills that haven't moved. Rep. Andy Barr (R-KY) and Rep. Angie Craig (D-MN) have the Lawful Hemp Protection Act, which would redefine hemp using a 1% total THC threshold measured on a dry-weight basis against the finished consumer product — a much more workable line than 0.4 milligrams per container, and one the industry has rallied around. Rep. Morgan Griffith and Rep. Marc Veasey have a competing HEMP Act, H.R. 7212, offering its own framework. Over in the Senate, Ron Wyden and Jeff Merkley have a bill of their own pending.

Then there's the beverage-specific angle. The Beverage Regulatory Parity Act, H.R. 10079, introduced August 10, 2026 by Rep. Beth Van Duyne (R-TX) and Rep. Greg Landsman (D-OH), would regulate hemp drinks the way alcohol gets regulated — under the Alcohol and Tobacco Tax and Trade Bureau, with a three-tier distribution system, a 21-and-over purchase rule, a 5 milligram per-serving THC cap, and an 8-cent-per-milligram excise tax. It's the most detailed of the bunch precisely because it only tries to solve one slice of the problem.

None of these bills had advanced past committee as of September 1. And the 2026 Farm Bill, which the House passed 224-200 back on April 30, left the hemp THC ban completely untouched — lawmakers punted the whole question to this separate track rather than folding a fix into farm policy where hemp's legal status originally got sorted out under an earlier Farm Bill.

State-Level Cannabis Headlines From the Same Week

Hemp wasn't the only regulatory story moving that week. California Gov. Gavin Newsom touted the state's cumulative $8.4 billion in marijuana tax revenue, pointing to how those dollars fund childcare programs, youth substance abuse prevention, medical research and environmental cleanup tied to illegal grow sites. In Oklahoma, regulators issued a statement on oversight practices after an explosion at a medical cannabis business killed two people; a suspect has since been charged with murder, and the case is likely to shape how the state inspects extraction and processing facilities going forward.

Elsewhere, a New York state senator was honored at the State Fair for cannabis policy work, a smaller but telling sign of how normalized cannabis advocacy has become in state politics. Oregon regulators opened a public comment period on proposed changes to psilocybin services rules, extending the state's regulatory experimentation beyond cannabis into other substances. And in Georgia, the state's top medical cannabis regulator talked about the ongoing project of educating law enforcement on patient legality protections — a reminder that even states with established medical programs still have basic awareness gaps to close.

Strip away the procedural noise and what happened on September 3 is simple: Congress moved a deadline, it didn't make a decision. A one-month delay isn't policy, and the political scaffolding behind it looks unusually fragile — the White House official who promised no further extensions is reportedly on his way out the door, which means nobody in particular is left holding that commitment when December 11 arrives.

Worth watching over the next few weeks: whether Barr-Craig, the Griffith-Veasey HEMP Act, Wyden-Merkley, or the narrower beverage bill from Van Duyne and Landsman actually gets a committee vote before the new deadline. If none of them do, and Congress reaches for a fourth straight punt, that will say something clear on its own — that lawmakers still can't agree on the basic question of what a legal hemp THC product should look like, years after an earlier Farm Bill opened this door in the first place.

And the federal fight isn't the whole story. California banking $8.4 billion in cumulative cannabis tax revenue and Oklahoma tightening safety oversight after a fatal explosion are both regulation stories too, just running on state tracks with their own timelines and their own stakes. Anyone trying to read where cannabis policy is headed needs to watch all of it at once — Congress isn't the only body deciding what accountable, regulated cannabis commerce actually looks like in practice.